Top of this page
Skip navigation, go straight to the content

Data Privacy Disclaimer

Publication of transfers of value to Recipients aims at reporting the values (monetary or in-kind) to HCPs/HCOs our company is collaborating / has relationships with, following the objectives and provisions included in the applicable codes.  Individual disclosures have been consented to by individual Recipients – such consent has been given to allow complying with the applicable codes that our company signed up to.

These publications do not grant a general permission for those accessing our website or the national platforms to undertake additional processing of the healthcare professionals’ data.

For a good understanding of the reporting included in our disclosures as published on this website, we refer to the Methodological Note that clarifies the meaning and content of the transfers of value reported.


Transfers of Value to Heath Professionals and Healthcare Organisations

In everything we do, we always start by asking ourselves “How can we create more value for people living with severe diseases?"

In the interest of patients, it is crucial for us to collaborate closely with healthcare professionals and organisations, who offer us invaluable and expert knowledge to provide solutions improving patients’ lives and treatments. This relationship has delivered significant innovations in healthcare so far and has made positive changes to the quality of life of numerous patients.

We aspire to maintain high standards of ethics and integrity in our interactions. We strongly believe that ensuring transparency in our financial relationships with healthcare professionals is essential to increase patients’ trust. Patients need to know that they can trust their doctors to recommend, prescribe and administer appropriate care and treatments based solely on clinical evidence and experience.

As a member company of EFPIA (European Federation of Pharmaceutical Industry and Associations), and of the ABPI (Association of the British Pharmaceutical Industry) we are committed to meeting their transparency code requirements and to report our transfers of value to healthcare stakeholders accordingly.

The UCB Pharma transfers of value data and the methodological note are published on the ABPI UK disclosure platform.  This can be accessed via the following web address. www.disclosureuk.org.uk